KIHT & CSIR–CGCRI partner to boost indigenous MedTech manufacturing

The Kalam Institute of Health Technology will facilitate the medical technology innovations from Central Glass and Ceramic Research Institute to promote local manufacturing thereby reducing import dependency


New Delhi: The Kalam Institute of Health Technology (KIHT), at the AP MedTech Zone, Visakhapatnam and Council of Scientific and Industrial Research (CSIR) – Central Glass and Ceramic Research Institute (CGCRI), Kolkata have signed a memorandum of understanding (MoU) on 4th January, 2019.

The mandate of KIHT created with support of DBT (Department of Biotechnology) is to reduce country’s import dependency and increase affordable medical devices through indigenous manufacturing, while CSIR-CGCRI mission is to provide scientific industrial research and development in the area of glass, ceramics and related materials that maximizes the economic, environmental and societal benefit for the people of India. Both these institutes are going to work together to transform the medical device implant industry where glass and ceramics are highly applied in bio-implants.

For the fiscal year 2017 – 2018, the import value of Biomedical Implants is approximately INR ₹2100 crores while export value is INR ₹400 crores. As a national lab CSIR-CGCRI is dedicated to carry out applied research in the fields of Bio Active Coating for Orthopaedic and Dental Application and Ceramic based hip joint prostheses and hydroxyapatite based integrated orbital implants which can significantly reduce the import dependency in the Biomedical implant and Biomaterial sector.

KIHT can facilitate these innovations of CSIR-CGCRI using its e-Auction portal where any interested Indian manufacturer can bid the technology and start indigenously manufacturing thereby reducing import dependency.

In addition, KIHT would support CSIR-CGCRI scientists, researchers, and students to engage with medical device companies, innovators, incubatees, R&D institutions, and technical service providers. KIHT also facilitates access to the Common Scientific Facilities (CSFs) of its affiliate company, AMTZ   for accelerating medical product development and commercialization. Further, both the institutes are going to encourage and facilitate industries, innovators, biomedical and related R&D institutions for exchange of information in relation to healthcare technology.